Latest Articles
The role of complementary lymphadenectomy in patients with incidental endometrial cancer - Frontiers
The role of complementary lymphadenectomy in patients with incidental endometrial cancer Frontiers
Published: Oct. 3, 2025, 9:32 a.m.
Ten-Year Single-Centre Study Compares Surgical Approaches for Advanced Endometrial Cancer - Docwire News
Ten-Year Single-Centre Study Compares Surgical Approaches for Advanced Endometrial Cancer Docwire News
Published: Oct. 2, 2025, 10:50 p.m.
Study Explores Link Between Irisin Hormone Levels and Endometrial Cancer Progression - geneonline.com
Study Explores Link Between Irisin Hormone Levels and Endometrial Cancer Progression geneonline.com
Published: Oct. 1, 2025, 12:08 a.m.
Intuition to Influence: Casey’s Endometrial Cancer Journey - Katie Couric Media
Intuition to Influence: Casey’s Endometrial Cancer Journey Katie Couric Media
Published: Sept. 30, 2025, 10:11 p.m.
Intuition to Influence: Casey’s Endometrial Cancer Journey - Yahoo
Intuition to Influence: Casey’s Endometrial Cancer Journey Yahoo
Published: Sept. 30, 2025, 9:16 p.m.
Microbiome Linked With Quality of Life, Symptoms in Endometrial Cancer - Cancer Nursing Today
Microbiome Linked With Quality of Life, Symptoms in Endometrial Cancer Cancer Nursing Today
Published: Sept. 30, 2025, 1:30 a.m.
Insurance coverage for GSK's Jemperli expanded to 1st-line endometrial cancer in Korea - koreabiomed.com
Insurance coverage for GSK's Jemperli expanded to 1st-line endometrial cancer in Korea koreabiomed.com
Published: Sept. 29, 2025, 8:16 a.m.
Ibuprofen Use Linked to Lower Risk of Endometrial Cancer - Oncology Nurse Advisor
Ibuprofen Use Linked to Lower Risk of Endometrial Cancer Oncology Nurse Advisor
Published: Sept. 29, 2025, 4 a.m.
Clinicopathological Characteristics and Oncologic Outcomes of Endometrioid Ovarian Carcinoma: A Retrospective Study from a Tertiary Cancer Centre.
Background/Objectives: To evaluate the clinicopathological features, treatment, and survival outcomes and to identify independent prognosticators for recurrence and mortality in patients with endometrioid ovarian cancer. Methods: The medical records of …
Published: Sept. 28, 2025, midnight
ASCENT-Gyn-01 Trial of Sacituzumab Govitecan Aims to Validate Clinical Utility of TROP2 ADCs in Pretreated Endometrial Cancer - OncLive
ASCENT-Gyn-01 Trial of Sacituzumab Govitecan Aims to Validate Clinical Utility of TROP2 ADCs in Pretreated Endometrial Cancer OncLive
Published: Sept. 26, 2025, 7:40 p.m.
Link copied to clipboard!